Gene · 6336
Papers2,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phase 2b Trial of a NaV1.8 Inhibitor for Acute Pain. | N Engl J Med | 2026 | 42526026 | PubTator, text mining | PubMed |
| Omega-3 Fatty Acids Attenuate Neuropathic Pain by Modulating Ferroptotic Stress, Selenoamino Acid Metabolism, and Lipid Remodeling. | Antioxidants (Basel) | 2026 | 42510583 | PubTator, text mining | PubMed |
| Response to Bradshaw et al "Suzetrigine for Acute Pain in the Emergency Department: A First-in-Class NaV1.8 Blocker." | J Am Coll Emerg Physicians Open | 2026 | 42495082 | PubTator, text mining | PubMed |
| Suzetrigine as Part of Multimodal Therapy Enables Opioid-Free Recovery After Aesthetic or Reconstructive Procedures. | Plast Reconstr Surg | 2026 | 42468001 | PubTator, text mining | PubMed |
| Dorsal Root Ganglion as a Hub for Peripheral Sensitization: A Hierarchical Regulation Model and Translational Progress. | J Pain Res | 2026 | 42454000 | PubTator, text mining | PubMed |
| Neural checkpoint therapy in lung cancer. | Trends Cancer | 2026 | 42443037 | PubTator, text mining | PubMed |
| Targeting Synaptic Vesicle Endocytosis in Nociceptors Provides Sustained Pain Relief. | bioRxiv | 2026 | 42395445 | PubTator, text mining | PubMed |
| Heart-Specific Spinal and Vagal Afferents: Transcriptomic Signatures and Optogenetically Modulated Functional Coupling With Cardiomyocytes. | Compr Physiol | 2026 | 42381253 | PubTator, text mining | PubMed |
| The real-world safety evaluation of the selective NaV1.8 inhibitor suzetrigine: disproportionality analysis and flexible empirical bayes signals from FAERS with external triangulation. | Front Pharmacol | 2026 | 42367302 | PubTator, text mining | PubMed |
| Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes. | Nat Commun | 2026 | 42337236 | PubTator, text mining | PubMed |
| Rapid generation of human sensory neurons from iPSC for modeling of peripheral neuropathies. | J Neurosci Methods | 2026 | 42336247 | PubTator, text mining | PubMed |
| Isoform-Specific NaV Modulation in Painful Chemotherapy-Induced Neuropathy: Promise, Limitations, and a Clinical Agenda. | CNS Drugs | 2026 | 42334794 | PubTator, text mining | PubMed |
| Association between voltage-gated sodium channel gene polymorphisms and chronic oxaliplatin-induced peripheral neuropathy in Japanese patients with colorectal cancer. | J Pharm Health Care Sci | 2026 | 42321904 | PubTator, text mining | PubMed |
| Modulation of ion channels as emerging therapeutic targets in the treatment of diabetic neuropathy. | EXCLI J | 2026 | 42318500 | PubTator, text mining | PubMed |
| Genetics of supraventricular tachycardia: current evidence with a focus on translational relevance and personalized medicine. | Front Cardiovasc Med | 2026 | 42291549 | PubTator, text mining | PubMed |
| A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Highly Selective NaV1.8 Inhibitor JKN2306 in Healthy Chinese Subjects. | Pharmacol Res Perspect | 2026 | 42290196 | PubTator, text mining | PubMed |
| Suzetrigine and the emergence of selective NaV1.8 inhibition in acute pain pharmacotherapy: efficacy, safety, and future clinical positioning. | Expert Opin Pharmacother | 2026 | 42281214 | PubTator, text mining | PubMed |
| Use of Suzetrigine for Treatment of Refractory Trigeminal Neuralgia in Four Patients: A Small Case Series. | A A Pract | 2026 | 42228878 | PubTator, text mining | PubMed |
| Defining cellular mechanisms important for painful chemotherapy-related neuropathy using long-term primary cultures of nociceptors. | FEBS J | 2026 | 42187779 | PubTator, text mining | PubMed |
| Targeting Arrhythmogenic Late Sodium Current by FHF1A-Derivative FixR in Heart Failure Cardiomyocytes. | Circ Res | 2026 | 42186805 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6336/papers?page=2